Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Medinova Diagnostic
Join Channel
Consolidated Standalone

Medinova Diagnostic

₹36.6 -1 | 2.7%

Market Cap ₹37 Cr.

Stock P/E 18.2

P/B -11.7

Current Price ₹36.6

Book Value ₹ -3.1

Face Value 10

52W High ₹64.5

Dividend Yield 0%

52W Low ₹ 21.9

Edit Ratio

Medinova Diagnostic Research see more...

Overview Inc. Year: 1993Industry: Hospital & Healthcare Services

Medinova Diagnostic Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Medinova Diagnostic Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 3 3 2 3 2 3 2 3 2 2
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 3 3 2 3 2 3 2 3 2 3
Total Expenditure 2 2 2 2 2 2 2 2 2 2
Operating Profit 1 1 1 1 0 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 1 0 1 0 1
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 1 0 1 0 1
Adjustments -0 -0 0 0 0 0 0 -0 0 0
Profit After Adjustments 0 0 0 0 0 1 0 1 0 1
Adjusted Earnings Per Share 0.4 0.3 0.3 0.4 0.2 0.8 0.3 0.7 0.4 0.6

Medinova Diagnostic Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 8 8 8 9 9 7 13 13 10 9
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 8 8 9 9 8 13 13 10 10
Total Expenditure 11 8 8 8 8 6 10 9 7 8
Operating Profit -3 0 0 1 1 1 3 4 3 4
Interest 0 1 1 1 1 1 0 1 1 0
Depreciation 1 2 3 2 1 1 1 1 0 0
Exceptional Income / Expenses 0 0 2 2 2 0 0 0 0 0
Profit Before Tax -4 -2 -2 -1 1 -0 2 3 2 2
Provision for Tax -1 -0 -0 -0 0 -0 0 0 0 0
Profit After Tax -4 -2 -2 -0 1 -0 2 2 2 2
Adjustments 0 0 0 0 -0 -0 0 -0 0 0
Profit After Adjustments -4 -2 -1 -0 1 -0 2 2 2 2
Adjusted Earnings Per Share -3.8 -2 -1.4 -0.3 0.8 -0.3 2 2.3 1.7 2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -23% 13% 2% 0%
Operating Profit CAGR -25% 44% 25% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 47% 6% 20% 21%
ROE Average 0% 0% 0% 0%
ROCE Average 2679% 893% 536% 298%

Medinova Diagnostic Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds -7 -9 -10 -10 -9 -9 -7 -7 -5
Minority's Interest 0 0 0 -0 -0 -0 -0 0 0
Borrowings 2 7 7 5 4 4 3 6 6
Other Non-Current Liabilities -0 -0 0 0 0 0 0 -0 -0
Total Current Liabilities 15 13 11 10 9 9 8 5 4
Total Liabilities 10 12 9 6 5 4 4 4 4
Fixed Assets 7 9 7 4 3 2 2 1 2
Other Non-Current Assets 0 1 0 0 0 1 0 0 1
Total Current Assets 3 2 1 1 1 1 2 2 2
Total Assets 10 12 9 6 5 4 4 4 4

Medinova Diagnostic Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 1
Cash Flow from Operating Activities 0 -1 0 1 1 1 2 1 1
Cash Flow from Investing Activities 0 -5 -0 0 -0 -0 -0 -2 -0
Cash Flow from Financing Activities 0 5 -0 -1 -1 -1 -1 0 -1
Net Cash Inflow / Outflow 0 0 -0 0 -0 0 0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 1

Medinova Diagnostic Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -3.8 -2.01 -1.43 -0.32 0.82 -0.26 2.03 2.28 1.67
CEPS(Rs) -2.71 -0.16 0.92 1.44 2.12 0.73 2.63 2.94 2
DPS(Rs) 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) -7.17 -9.18 -9.61 -9.75 -8.95 -9.21 -7.23 -6.84 -5.16
Core EBITDA Margin(%) -44.59 -0.43 1.38 6.74 14.72 16.05 23.58 28.46 26.49
EBIT Margin(%) -51.76 -21.89 -10.08 3.79 19.48 4.27 19.03 25.46 25.48
Pre Tax Margin(%) -54.75 -28.37 -23.66 -5.94 12.14 -3.7 15.4 21.19 19.01
PAT Margin (%) -46.68 -25.65 -22.37 -5.23 9.17 -3.06 14.95 18.03 16.66
Cash Profit Margin (%) -33.25 -1.89 11.76 16.5 23.49 9.71 20.57 22.17 19.92
ROA(%) -36.06 -18.68 -16.82 -6.27 15.7 -5.45 48.36 60.03 42.82
ROE(%) 0 0 0 0 0 0 0 0 0
ROCE(%) 0 0 0 0 0 0 0 0 2679.22
Receivable days 34.31 26.88 18.12 10.83 13.64 19.87 16.77 18.57 22.29
Inventory Days 8.55 7.71 6.13 4.33 4.06 4.32 3.26 4.47 5.46
Payable days 3454.07 2100.76 1350.12 1166.03 1249.1 1622.8 1092.59 563.96 822.93
PER(x) 0 0 0 0 31.93 0 11.28 13.87 10.49
Price/Book(x) -3.94 -2.24 -3.64 0 -2.91 -1.54 -3.17 -4.62 -3.4
Dividend Yield(%) 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 3.71 3.5 5.55 1.97 3.6 2.63 2.08 2.77 2.25
EV/Core EBITDA(x) -9.68 187.41 173.87 29.18 22.75 15.44 8.46 9.35 7.81
Net Sales Growth(%) 0 4.81 -3.39 11.28 3.49 -17 71.12 3.6 -24.31
EBIT Growth(%) 0 55.68 55.53 141.85 432.18 -81.81 662.52 38.62 -24.24
PAT Growth(%) 0 42.41 15.73 74 281.58 -127.67 936.5 24.99 -30.05
EPS Growth(%) 0 47.01 28.92 77.52 353.68 -131.79 883.16 12.17 -26.58
Debt/Equity(x) -0.28 -1.03 -0.88 -0.75 -0.72 -0.62 -0.62 -0.94 -1.12
Current Ratio(x) 0.2 0.17 0.12 0.12 0.11 0.08 0.22 0.4 0.47
Quick Ratio(x) 0.19 0.16 0.11 0.11 0.1 0.07 0.2 0.36 0.44
Interest Cover(x) -17.31 -3.38 -0.74 0.39 2.65 0.54 5.24 5.96 3.94
Total Debt/Mcap(x) 0.07 0.46 0.24 0 0.25 0.4 0.2 0.2 0.33

Medinova Diagnostic Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 62.14 62.14 62.14 62.14 62.14 62.14 62.14 62.14 62.14 62.14
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 37.86 37.86 37.86 37.86 37.86 37.86 37.86 37.86 37.86 37.86
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at -11.7 times its book value
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 0% over the last 3 years.
  • Debtor days have increased from 563.96 to 822.93days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Medinova Diagnostic News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!